These results, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two support the thought of targeting ACKR3 as a unique method to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders. On top of that, the https://proleviate.com/